Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
JAMA Oncology|July 15, 2016
Incidence of Oropharyngeal Cancer Among Elderly Patients in the United StatesZachary S Zumsteg, Galen Cook-Wiens, Emi Yoshida, et al.
Cancer Chemotherapy and Pharmacology|May 13, 2014
Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanomaDevalingam Mahalingam, Laeeq Malik, Muralidhar Beeram, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 15, 2003
The absence of functional glucosylceramide synthase does not sensitize melanoma cells for anticancer drugsRobert Jan Veldman, Alain Mita, Olivier Cuvillier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
Phase I and pharmacokinetic study of trabectedin as a 1- or 3-hour infusion weekly in patients with advanced solid malignanciesBahram Forouzesh, Manuel Hidalgo, Quincy Chu, et al.
Investigational New Drugs|August 25, 2012
Metabolism of patupilone in patients with advanced solid tumor malignanciesKevin R Kelly, Markus Zollinger, Frédéric Lozac'h, et al.
Head & Neck|February 9, 2018
Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classificationEmi J Yoshida, Michael Luu, John M David, et al.
British Journal of Clinical Pharmacology|November 15, 2018
Physiologically-based pharmacokinetic modelling to predict oprozomib CYP3A drug-drug interaction potential in patients with advanced malignanciesYing Ou, Yang Xu, Lia Gore, et al.
Molecular Cancer Therapeutics|January 12, 2011
Effects of patupilone on the pharmacokinetics and pharmacodynamics of warfarin in patients with advanced malignancies: a phase I clinical trialApostolia-Maria Tsimberidou, Chris H M Takimoto, Stacy Moulder, et al.
Oral Oncology|November 10, 2019
Survival outcomes with concomitant chemoradiotherapy in older adults with oropharyngeal carcinoma in an era of increasing human papillomavirus (HPV) prevalenceDiana J Lu, Michael Luu, Anthony T Nguyen, et al.
Oral Oncology|July 11, 2020
The role of concomitant chemoradiotherapy in AJCC 7<sup>th</sup> edition T1-2N1 oropharyngeal carcinoma in the human papillomavirus eraDiana J Lu, Michael Luu, Anthony T Nguyen, et al.
Pageof 6